XML 143 R53.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Selected Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Selected Quarterly Financial Data | The following table presents selected unaudited quarterly financial data for 201 9 and 201 8 :
|  | 2019 |
|  | 4th quarter |  |  | 3rd quarter |  |  | 2nd quarter |  |  | 1st quarter |
|  | (U.S $ in millions except per share amounts) |
Net revenues * |  |  | 4,468 |  |  |  | 4,093 |  |  |  | 4,177 |  |  |  | 4,149 |
Gross profit |  |  | 1,958 |  |  |  | 1,830 |  |  |  | 1,893 |  |  |  | 1,856 |
Net income (loss) |  |  | 75 |  |  |  | (307 | ) |  |  | (671 | ) |  |  | (97 | )
Net income (loss) attributable to Teva |  |  | 110 |  |  |  | (314 | ) |  |  | (689 | ) |  |  | (105 | )
Net income (loss) attributable to ordinary shareholders |  |  | 110 |  |  |  | (314 | ) |  |  | (689 | ) |  |  | (105 | )
Earnings per share attributable to ordinary shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 0.10 |  |  |  | (0.29 | ) |  |  | (0.63 | ) |  |  | (0.10 | )
Diluted |  |  | 0.10 |  |  |  | (0.29 | ) |  |  | (0.63 | ) |  |  | (0.10 | )
|  | 2018 |
|  | 4th quarter |  |  | 3rd quarter |  |  | 2nd quarter |  |  | 1st quarter |
|  | (U.S $ in millions except per share amounts) |
Net revenues * |  |  | 4,419 |  |  |  | 4,385 |  |  |  | 4,552 |  |  |  | 4,916 |
Gross profit |  |  | 1,971 |  |  |  | 1,977 |  |  |  | 2,033 |  |  |  | 2,315 |
Net income (loss) |  |  | (3,243 | ) |  |  | (197 | ) |  |  | (166 | ) |  |  | 1,134 |
Net income (loss) attributable to Teva |  |  | (2,886 | ) |  |  | (208 | ) |  |  | (176 | ) |  |  | 1,120 |
Net income (loss) attributable to ordinary shareholders |  |  | (2,940 | ) |  |  | (273 | ) |  |  | (241 | ) |  |  | 1,055 |
Earnings per share attributable to ordinary shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | (2.85 | ) |  |  | (0.27 | ) |  |  | (0.24 | ) |  |  | 1.04 |
Diluted |  |  | (2.85 | ) |  |  | (0.27 | ) |  |  | (0.24 | ) |  |  | 1.03 |
* | The data presented for prior periods have been revised to reflect a revision in the presentation of net revenues and cost of sales in the consolidated financial statements. See table below and not e 1b.
Summary of the impact of the revision on net revenues and cost of sales | The following table summarizes the impact of the revision on net revenues and cost of sales in the consolidated statement of income for the relevant periods:
|  |  |  |  | Net revenues |  |  | Cost of sales |
|  |  |  |  | As reported |  |  | Adjustment |  |  | As revised |  |  | As reported |  |  | Adjustment |  |  | As revised |
|  |  |  |  | (U.S. $ in millions) |
2018 |  |  | Q1 |  |  |  | 5,065 |  |  |  | (149 | ) |  |  | 4,916 |  |  |  | 2,750 |  |  |  | (149 | ) |  |  | 2,601 |
| Q2 |  |  |  | 4,701 |  |  |  | (150 | ) |  |  | 4,552 |  |  |  | 2,668 |  |  |  | (150 | ) |  |  | 2,518 |
| Q3 |  |  |  | 4,529 |  |  |  | (143 | ) |  |  | 4,385 |  |  |  | 2,552 |  |  |  | (143 | ) |  |  | 2,409 |
| Q4 |  |  |  | 4,559 |  |  |  | (141 | ) |  |  | 4,419 |  |  |  | 2,588 |  |  |  | (141 | ) |  |  | 2,447 |
2019 |  |  | Q1 |  |  |  | 4,295 |  |  |  | (146 | ) |  |  | 4,149 |  |  |  | 2,440 |  |  |  | (146 | ) |  |  | 2,293 |
| Q2 |  |  |  | 4,337 |  |  |  | (159 | ) |  |  | 4,177 |  |  |  | 2,443 |  |  |  | (159 | ) |  |  | 2,284 |
| Q3 |  |  |  | 4,264 |  |  |  | (171 | ) |  |  | 4,093 |  |  |  | 2,435 |  |  |  | (171 | ) |  |  | 2,264 |

X
- Definition Impact Of The Revision On Net Revenues And Cost Of Sales In The Consolidated Statement Of Income. + References No definition available. + Details
Name: | teva_ImpactOfTheRevisionOnNetRevenuesAndCostOfSalesInTheConsolidatedStatementOfIncomeTableTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Selected Quarterly Financial Data Table [Text Block] + References No definition available. + Details
Name: | teva_SelectedQuarterlyFinancialDataTableTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration